Artificial Intelligence in Ophthalmology – Threat or Aid? Review article

Article Sidebar

PDF


Published: Jun 12, 2024
DOI: https://doi.org/10.24292/01.OT.200524
Keywords:
artificial intelligence, medical ethics, public health, diabetic retinopathy, legal regulation, machine learning

Main Article Content

Jakub Joński
Provincial Hospital in Włocławek
https://orcid.org/0009-0004-6184-9283
Karolina Jońska
Private Health Care Center Medical Clinic „Eskulap”
https://orcid.org/0009-0002-5677-5983

Abstract

Objective: This review seeks to identify and analyze the drawbacks and advantages associated with the integration of artificial intelligence (AI) into the field of ophthalmology.


Methods: A comprehensive review of scientific literature, articles, and publications on PubMed was undertaken. Various aspects, including the effectiveness and diagnostic speed of diabetic retinopathy, as well as ethical considerations and data security, were evaluated. Results were meticulously checked, compared, and summarized. In total, 98 articles were scrutinized using keywords in both Polish and English, including “artificial intelligence,” “ethics,” “diabetic retinopathy,” and “machine learning.”


Results and discussion: The application of AI in ophthalmology demonstrates significant potential in improving the diagnosis of diabetic retinopathy. AI-based systems not only contribute to facilitating and streamlining the diagnostic and therapeutic processes but also enhance therapy efficiency. However, issues related to patient data protection, physician responsibility, the cost of training adequately skilled personnel, trust in the accuracy of diagnoses, and the long-term consequences of replacing human intervention with AI necessitate careful consideration.


Conclusions: AI presents substantial opportunities in ophthalmology but simultaneously poses challenges that demand diligence and attention. It is imperative to develop norms and guidelines for the responsible use of AI in ophthalmic practice, ensuring benefits for patients while minimizing potential risks and maintaining high ethical standards. This proactive approach is crucial for harnessing the full potential of AI in healthcare.

Downloads

Download data is not yet available.

Article Details

How to Cite
1.
Joński J, Jońska K. Artificial Intelligence in Ophthalmology – Threat or Aid?. Ophthatherapy [Internet]. 2024Jun.12 [cited 2024Dec.21];11(2):113-8. Available from: https://journalsmededu.pl/index.php/ophthatherapy/article/view/2904
Issue
Vol 11 No 2 (2024)
Section
Diagnostics
Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

Copyright: © Medical Education sp. z o.o. License allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material, provided the original work is properly cited and states its license.

Address reprint requests to: Medical Education, Marcin Kuźma (marcin.kuzma@mededu.pl)

References

1. Price WN 2nd, Cohen IG. Privacy in the age of medical big data. Nat Med. 2019; 25(1): 37-43. http://doi.org/10.1038/s41591-018-0272-7.
2. Marling C, Wiley M, Bunescu R et al. Emerging Applications for Intelligent Diabetes Management. AI Magazine. 2012; 33: 67-78. https://doi.org/10.1609/aimag.v33i2.2410.
3. Schmidt R, Montani S, Bellazzi R et al. Cased-Based reasoning for medical knowledge-based systems. Int J Med Inform. 2001; 64(2-3): 355-67. https://doi.org/10.1016/S1386-5056(01)00221-0.
4. Ting DSW, Cheung CY, Lim G et al. Development and Validation of a Deep Learning System for Diabetic Retinopathy and Related Eye Diseases Using Retinal Images From Multiethnic Populations With Diabetes. JAMA. 2017; 318(22): 2211-23. https://doi.org/10.1001/jama.2017.18152.
5. Odedra D, Samanta S, Vidyarthi AS. Computational intelligence in early diabetes diagnosis: a review. Rev Diabet Stud. 2010; 7(4): 252-62. https://doi.org/10.1900/RDS.2010.7.252.
6. Ramesh AN, Kambhampati C, Monson JR et al. Artificial intelligence in medicine. Ann R Coll Surg Engl. 2004; 86(5): 334-8. https://doi.org/10.1308/147870804290.
7. Pandey B, Mishra RB. Knowledge and intelligent computing system in medicine. Comput Biol Med. 2009; 39(3): 215-30. https://doi.org/10.1016/j.compbiomed.2008.12.008.
8. Brause RW. Revolutionieren Neuronale Netze unsere Vorhersagefähigkeiten? [Do neural networks revolutionize our predictive abilities?]. Zentralbl Chir. 1999; 124(8): 692-8.
9. Gulshan V, Peng L, Coram M et al. Development and validation of a deep learning algorithm for detection of diabetic retinopathy in retinal fundus photographs. JAMA. 2016; 316: 2402-10. https://doi.org/10.1001/jama.2016.17216.
10. Yau JWY, Rogers SL, Kawasaki R et al.Global Incidence Rate and Key Risk Factors of Diabetic Retinopathy. Diabetes Care. 2012; 35: 556-64. https://doi.org/10.2337/dc11-1909.
11. Sabanayagam C, Yip W, Ting DSW et al. Ten New Trends in the Epidemiology of Diabetic Retinopathy. Ophthalmic Epidemiology. 2016; 23: 209-22. https://doi.org/10.1080/09286586.2016.1193618.
12. Wong TY, Mwamburi M, Klein R et al. Rates of progression in diabetic retinopathy during different time periods: a systematic review and meta-analysis. Diabetes Care. 2009; 32(12): 2307-13. https://doi.org/10.2337/dc09-0615.
13. Sosale B, Aravind SR, Murthy H et al. Simple, mobile-based artificial intelligence algorithm in the detection of diabetic retinopathy (SMART) study. BMJ Open Diabetes Res Care. 2020; 8(1): e000892. https://doi.org/10.1136/bmjdrc-2019-000892.
14. Chat GPT Research. Online.
15. Chatterjee J, Dethlefs N. This new conversational AI model can be your friend, philosopher, and guide... and even your worst enemy. Patterns (NY). 2023; 4(1): 100676. https://doi.org/10.1016/j.patter.2022.100676.
16. Royal College of Physicians. Improving discharge summaries—learning resource materials. RCP London. 2021.
17. Earnshaw CH, Pedersen A, Evans J et al. Improving the quality of discharge summaries through a direct feedback system. Future Healthc J. 2020; 7(2): 149-54. https://doi.org/10.7861/fhj.2019-0046.
18. Baker A, Perov Y, Middleton K et al. A Comparison of Artificial Intelligence and Human Doctors for the Purpose of Triage and Diagnosis. Front Artif Intell. 2020; 3: 543405. https://doi.org/10.3389/frai.2020.543405.
19. Bhaskaranand M, Ramachandra C, Bhat S et al. The Value of Automated Diabetic Retinopathy Screening with the EyeArt System: A Study of More Than 100,000 Consecutive Encounters from People with Diabetes. Diabetes Technol Ther. 2019; 21(11): 635-43. https://doi.org/10.1089/dia.2019.0164.
20. Flaxel CJ, Adelman RA, Bailey ST et al. Diabetic Retinopathy Preferred Practice Pattern®. Ophthalmology. 2020; 127(1): P66-145.
21. Early Treatment Diabetic Retinopathy Study Research Group. Grading diabetic retinopathy from stereoscopic color fundus photographs – an extension of the modified Airlie House classification. ETDRS report number 10. Ophthalmology. 1991; 98(5 Suppl): 786-806.
22. Ustawa z 10 maja 2018 o ochronie danych osobowych (Dz.U. 2019 r. poz. 1781).
23. World Health Organisation. WHO Guideline: Recommendations on Digital Interventions for Health System Strengthening. 2019.
24. New Regulations on Product Liability and Artificial Intelligence (AI) Aimed at Protecting Consumers and Supporting Innovation (2022, September 28).
25. Li JO, Liu H, Ting DSJ et al. Digital technology, tele-medicine and artificial intelligence in ophthalmology: A global perspective. Prog Retin Eye Res. 2021; 82: 100900. https://doi.org/10.1016/j.preteyeres.2020.100900.
26. Wong TY, Sabanayagam C. The War on Diabetic Retinopathy: Where Are We Now? Asia Pac J Ophthalmol (Phila). 2019; 8(6): 448-56. https://doi.org/10.1097/apo.0000000000000267.
27. Botsis T, Hartvigsen G, Chen F et al. Secondary Use of EHR: Data Quality Issues and Informatics Opportunities. Summit Transl Bioinform. 2010; 2010: 1-5.
28. Sterne JA, White IR, Carlin JB et al. Multiple imputation for missing data in epidemiological and clinical research: potential and pitfalls. BMJ. 2009; 338: b2393. https://doi.org/10.1136/bmj.b2393.
29. Abdullah YI, Schuman JS, Shabsigh R et al. Ethics of Artificial Intelligence in Medicine and Ophthalmology. Asia Pac J Ophthalmol (Phila). 2021; 10(3): 289-98. https://doi.org/10.1097/apo.0000000000000397.
30. Grech V, Cuschieri S, Eldawlatly AA. Artificial intelligence in medicine and research - the good, the bad, and the ugly. Saudi J Anaesth. 2023; 17(3): 401-6. https://doi.org/10.4103/sja.sja_344_23.
31. Mathews SC, McShea MJ, Hanley CL et al. Digital health: a path to validation. NPJ Digit Med. 2019; 2: 38. https://doi.org/10.1038/s41746-019-0111-3.
32. Straňák Z, Penčák M, Veith M. Arteficial intelligence in diabetic retinopathy screening. A review. Cesk Slov Oftalmol. 2021; 77(5): 224-31. https://doi.org/10.31348/2021/6.
33. Kulkarni S, Seneviratne N, Baig MS et al. Artificial Intelligence in Medicine: Where Are We Now? Acad Radiol. 2020; 27(1): 62-70. https://doi.org/10.1016/j.acra.2019.10.001.
34. Scanlon PH. The English National Screening Programme for diabetic retinopathy 2003-2016. Acta Diabetol. 2017; 54(6): 515-25. https://doi.org/10.1007/s00592-017-0974-1.
35. Burlina PM, Joshi N, Pekala M et al. Automated Grading of Age-Related Macular Degeneration From Color Fundus Images Using Deep Convolutional Neural Networks. JAMA Ophthalmol. 2017; 135(11): 1170-6. https://doi.org/10.1001/jamaophthalmol.2017.3782.
36. Abràmoff MD, Leng T, Ting DSW et al. Automated and Computer-Assisted Detection, Classification, and Diagnosis of Diabetic Retinopathy. Telemed J E Health. 2020; 26(4): 544-50. https://doi.org/10.1089/tmj.2020.0008.
37. American Medical Association. Augmented intelligence in health care. Policy 2019.
38. Azencott CA. Machine learning and genomics: precision medicine versus patient privacy. Philos Trans A Math Phys Eng Sci. 2018; 376(2128): 20170350. https://doi.org/10.1098/rsta.2017.0350.
39. Floridi L, Taddeo M. What is data ethics? Philos Trans A Math Phys Eng Sci. 2016; 374(2083): 20160360. https://doi.org/10.1098/rsta.2016.0360.